SCHEMBL4788930

SCHEMBL4788930

CNc1c(C(=O)Nc2cc(Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)ccc2C)cnc2[nH]ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.53
MAP3K20 Q9NYL2 1/20 0.53
MAP3K7 O43318 1/20 0.53
MAP4K2 Q12851 1/20 0.53
EPHB2 P29323 1/20 0.52
RAF1 P04049 1/20 0.51
NR2E1 Q9Y466 6/20 0.51
CSF1R P07333 1/20 0.51
MAPT P10636 1/20 0.49
HCK P08631 1/20 0.49
NR2C2 P49116 1/20 0.49
BTK Q06187 1/20 0.49
ABL1 P00519 3/20 0.48
MEN1 O00255 1/20 0.47
OPRK1 P41145 1/20 0.47
KMT2A Q03164 1/20 0.47
BCR P11274 2/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4788935 0.91 CSF1R (0.63) MAPK14MAP3K20MAP3K7MAP4K2EPHB2
SCHEMBL4787135 0.88 MAP3K7 (0.61) MAPK14MAP3K20MAP3K7MAP4K2EPHB2
SCHEMBL4789920 0.86 KDR (0.44) MAPK14RAF1CSF1RBTKABL1
SCHEMBL4788889 0.84 BMX (0.53) MAPK14RAF1CSF1RMAPTBTK
SCHEMBL4788673 0.84 MAP3K7 (0.45) MAPK14MAP3K20MAP3K7MAP4K2RAF1
SCHEMBL4788636 0.83 EPHB2 (0.59) MAPK14MAP3K20MAP3K7MAP4K2EPHB2
SCHEMBL4788852 0.80 BRAF (0.43) MAPK14RAF1ABL1
SCHEMBL4788092 0.79 BRAF (0.53) MAPK14RAF1BTK
SCHEMBL4787141 0.78 CSF1R (0.67) MAPK14MAP3K20MAP3K7MAP4K2EPHB2
SCHEMBL4789921 0.78 KDR (0.48) MAPK14RAF1CSF1RABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008144253-A1 PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF IRM LLC (BM) 2008-11-27 WO disclosed